CompoAtlas

Spermidin

Food supplement declared in France, decision dated 30 October 2026

Spermidin (MOLEQLAR) is a food supplement declared in France. Status: declared in France, may be marketed. 1 rule of use applies to its ingredients (limits and warnings).

Brand
MOLEQLAR
Food business operator placing the product on the market
MoleQlar GmbH
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
2
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Digestion

Declaration 380985, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Chlorella vulgaris BeijerinckPlante entièrePoudre (de plantes séchées ou broyées)700 mg
Glycine max. (L.) Merr.GraineAlcoolat500 mg

Additives

E464

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Chlorella vulgaris Beijerinck
    Read the warning, when it applies and the studies cited

    CHLORELLA - CHLORELLA VULGARIS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products providing 250 mg or more of chlorella per day or 6 µg or more vitamin K per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Ohkawa et al. 1995; NNHPD Multi-vitamin/mineral supplements monograph).

    Sources cited by Health Canada (1)
    • Ohkawa S, Yoneda Y, Ohsumi Y, Tabuchi M. Warfarin therapy and chlorella. Rinsho Shinkeigaku 1995;35(7):806-807. PubMed Case report

    Applies to products containing chlorella enriched with selenium and providing more than 70 µg of selenium per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of non-melanoma skin cancer (Doucha et al. 2009; NNHPD Multi-vitamin/mineral supplements monograph).

    Sources cited by Health Canada (1)
    • Doucha J, Livansky K, Kotrbacek V, Zachleder V. Production of Chlorella biomass enriched by selenium and its use in animal nutrition: a review. Applied Microbiology and Biotechnology 2009;83(6):1001-1008. PubMed Review article

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Tiberg et al. 1995).

    Sources cited by Health Canada (1)
    • Tiberg E, Dreborg S, Bjorksten B. Allergy to green algae (Chlorella) among children. Journal of Allergy and Clinical Immunology 1995;96(2):257-259. PubMed

    Health Canada monograph dated 27 June 2025

  • Glycine max. (L.) Merr.
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : MOLEQLAR

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line